Suppr超能文献

国际妇产科联盟(FIGO)IB期腺癌与鳞状细胞癌预后的比较。

A comparison of prognoses of FIGO stage IB adenocarcinoma and squamous cell carcinoma.

作者信息

Ayhan A, Al R A, Baykal C, Demirtas E, Yüce K, Ayhan A

机构信息

Department of Obstetrics and Gynecology, Gynecologic Oncology Unit, Hacettepe University School of Medicine, Hacettepe University Hospitals, 06100 Sihhye, Ankara, Turkey.

出版信息

Int J Gynecol Cancer. 2004 Mar-Apr;14(2):279-85. doi: 10.1111/j.1048-891X.2004.014211.x.

Abstract

OBJECTIVES

The objective of this study was to compare clinical and pathologic variables and prognosis of FIGO stage IB adenocarcinoma and squamous cell carcinoma of uterine cervix.

METHODS

A retrospective review was performed of 521 patients with stage IB squamous cell carcinoma and adenocarcinoma of cervix who treated primarily by type 3 hysterectomy and pelvic and/or para-aortic lymphadenectomy at Hacettepe University Hospitals between 1980 and 1997.

RESULTS

Age, tumor size, grade, depth of invasion, lymph node metastasis, parametrial, vaginal, and lymphvascular space involvement (LVSI) were not different between two cell types except number of the lymph nodes involved. Metastasis to three or more lymph nodes was significantly higher in adenocarcinoma. Overall and disease-free survival were 87.7%, 84.0% versus 86.4%, 83.1% for squamous cell carcinoma and adenocarcinoma, respectively (P > 0.05). The rate and site of recurrence were not different between two cell types. Multivariate analysis of disease-free and overall survival revealed independent prognostic factors as tumor size, LVSI, number of involved lymph node, and vaginal involvement.

CONCLUSION

Prognosis of FIGO stage IB cervical cancer patients who were treated by primarily radical surgery was found to be same for those with adenocarcinoma and squamous cell carcinoma.

摘要

目的

本研究的目的是比较国际妇产科联盟(FIGO)IB期子宫颈腺癌和鳞状细胞癌的临床、病理变量及预后。

方法

对1980年至1997年间在哈杰泰佩大学医院接受3型子宫切除术及盆腔和/或腹主动脉旁淋巴结切除术为主治疗的521例IB期子宫颈鳞状细胞癌和腺癌患者进行回顾性研究。

结果

除受累淋巴结数量外,两种细胞类型在年龄、肿瘤大小、分级、浸润深度、淋巴结转移、宫旁组织、阴道及淋巴血管间隙浸润(LVSI)方面无差异。腺癌转移至三个或更多淋巴结的情况显著更高。鳞状细胞癌和腺癌的总生存率及无病生存率分别为87.7%、84.0%和86.4%、83.1%(P>0.05)。两种细胞类型的复发率及复发部位无差异。对无病生存和总生存的多因素分析显示,独立预后因素为肿瘤大小、LVSI、受累淋巴结数量及阴道受累情况。

结论

对于接受主要根治性手术治疗的FIGO IB期子宫颈癌患者,腺癌和鳞状细胞癌患者的预后相同。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验